Revance Therapeutics, Inc. (NASDAQ: RVNC)

This investigation is for anyone who acquired securities in Revance Therapeutics, Inc. (NASDAQ: RVNC) prior to September 23, 2024.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that, throughout the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by telling investors that the Company complied with applicable laws but then by violating federal securities laws.

On September 23, 2024, Revance disclosed in a filing with the U.S. Securities and Exchange Commission that it had “received a notice to remedy alleged material breaches, including breaches of the maximum levels of buffer stock and required efforts to promote and sell Teoxane products, under the Company’s exclusive distribution agreement with Teoxane SA.” On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Revance Therapeutics, Inc. (NASDAQ: RVNC) prior to September 23, 2024 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.